XML 21 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Series A Preferred Stock
Series B Preferred Stock
Preferred Stock, Cumulative Redeemable - Liquidation Preference $25.00 per Share:
Series A Preferred Stock
Preferred Stock, Cumulative Redeemable - Liquidation Preference $25.00 per Share:
Series B Preferred Stock
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Series A Preferred Stock
Additional Paid-in Capital
Series B Preferred Stock
Accumulated Deficit
Accumulated Other Comprehensive Income
Balance at Dec. 31, 2012 $ 3,311,006     $ 38 $ 0 $ 3,575 $ 2,805,724     $ (260,308) $ 761,977
Balance (in shares) at Dec. 31, 2012       3,840 0 357,546          
Increase (Decrease) in Stockholders' Equity                      
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing 0                   0
Net income 302,709                 302,709  
Issuance of stock, net of expenses 77,625 [1]   $ 193,316   $ 80 $ 97 [1] 77,528 [1]   $ 193,236    
Issuance of common stock, net of expenses (in shares)         8,000 9,855 [1]          
Redemption of Series A Preferred Stock   $ (92,053)   $ (38)       $ (92,015)      
Redemption of Series A Preferred Stock (in shares)       (3,840)              
Repurchase of shares of common stock [1] (16,281)         $ (21) (16,260)        
Repurchase of shares of common stock (in shares) [1]           (2,276)          
Equity based compensation expense 4,156           4,156        
Dividends declared on common stock (594,318)                 (594,318)  
Dividends declared on preferred stock (13,750)                 (13,750)  
Dividends attributable to dividend equivalents (1,930)                 (1,930)  
Issuance cost of redeemed Preferred stock (3,947)                 (3,947)  
Change in unrealized gains/(losses) on MBS and CRT securities, net (71,896)                   (71,896)
Change in unrealized gains/(losses) on derivative hedging instruments, net 47,614                   47,614
Balance at Dec. 31, 2013 3,142,251     $ 0 $ 80 $ 3,651 2,972,369     (571,544) 737,695
Balance (in shares) at Dec. 31, 2013       0 8,000 365,125          
Increase (Decrease) in Stockholders' Equity                      
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing 0                   0
Net income 313,504                 313,504  
Issuance of stock, net of expenses [1] 35,640         $ 50 35,590        
Issuance of common stock, net of expenses (in shares) [1]           5,305          
Repurchase of shares of common stock [1] (2,688)           (2,688)        
Repurchase of shares of common stock (in shares) [1]           (346)          
Equity based compensation expense 8,581           8,581        
Accrued dividends attributable to stock-based awards (218)           (218)        
Dividends declared on common stock (294,792)                 (294,792)  
Dividends declared on preferred stock (15,000)                 (15,000)  
Dividends attributable to dividend equivalents (764)                 (764)  
Change in unrealized gains/(losses) on MBS and CRT securities, net 60,603                   60,603
Change in unrealized gains/(losses) on derivative hedging instruments, net (43,845)                   (43,845)
Balance at Dec. 31, 2014 3,203,272       $ 80 $ 3,701 3,013,634     (568,596) 754,453
Balance (in shares) at Dec. 31, 2014         8,000 370,084          
Increase (Decrease) in Stockholders' Equity                      
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing 4,537                 (4,537) 4,537
Net income 313,226                 313,226  
Issuance of stock, net of expenses [1] 1,221         $ 5 1,216        
Issuance of common stock, net of expenses (in shares) [1]           809          
Repurchase of shares of common stock [1] (2,273)           (2,273)        
Repurchase of shares of common stock (in shares) [1]           (309)          
Equity based compensation expense 7,829           7,829        
Accrued dividends attributable to stock-based awards (450)           (450)        
Dividends declared on common stock (296,384)                 (296,384)  
Dividends declared on preferred stock (15,000)                 (15,000)  
Dividends attributable to dividend equivalents (1,041)                 (1,041)  
Change in unrealized gains/(losses) on MBS and CRT securities, net (232,802)                   (232,802)
Change in unrealized gains/(losses) on derivative hedging instruments, net (10,337)                   (10,337)
Balance at Dec. 31, 2015 $ 2,967,261       $ 80 $ 3,706 $ 3,019,956     $ (572,332) $ 515,851
Balance (in shares) at Dec. 31, 2015         8,000 370,584          
[1] For the year ended December 31, 2015, includes approximately $2.3 million (309,206 shares) surrendered for tax purposes related to equity-based compensation awards. For the year ended December 31, 2014, includes approximately $2.7 million (345,559 shares) surrendered for tax purposes related to equity-based compensation awards. For the year ended December 31, 2013, includes approximately $15.4 million (2,143,354 shares) repurchased through the Company’s publicly announced stock repurchase program and approximately $849,000 (132,276 shares) surrendered for tax purposes related to equity-based compensation awards.